INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Debt-to-equity in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Integra Lifesciences Holdings Corp quarterly Debt-to-equity history and growth rate from Q1 2011 to Q3 2024.
  • Integra Lifesciences Holdings Corp Debt-to-equity for the quarter ending September 30, 2024 was 156 %, a 25.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 156 +31.6 +25.4% Sep 30, 2024
Q2 2024 149 +27.9 +23% Jun 30, 2024
Q1 2024 138 +17.2 +14.1% Mar 31, 2024
Q4 2023 131 +8.3 +6.79% Dec 31, 2023
Q3 2023 125 +0.12 +0.1% Sep 30, 2023
Q2 2023 121 -6.3 -4.95% Jun 30, 2023
Q1 2023 121 -8.33 -6.43% Mar 31, 2023
Q4 2022 122 -11.6 -8.65% Dec 31, 2022
Q3 2022 125 -12.9 -9.38% Sep 30, 2022
Q2 2022 127 -14.1 -9.98% Jun 30, 2022
Q1 2022 130 -15.6 -10.7% Mar 31, 2022
Q4 2021 134 -14.4 -9.72% Dec 31, 2021
Q3 2021 137 -9.48 -6.45% Sep 30, 2021
Q2 2021 141 -4.23 -2.91% Jun 30, 2021
Q1 2021 145 +4.64 +3.3% Mar 31, 2021
Q4 2020 148 +14.3 +10.6% Dec 31, 2020
Q3 2020 147 +14.8 +11.2% Sep 30, 2020
Q2 2020 146 +15.6 +12% Jun 30, 2020
Q1 2020 141 +9.24 +7.03% Mar 31, 2020
Q4 2019 134 -16.4 -10.9% Dec 31, 2019
Q3 2019 132 -42.6 -24.4% Sep 30, 2019
Q2 2019 130 -56.2 -30.2% Jun 30, 2019
Q1 2019 131 -60 -31.3% Mar 31, 2019
Q4 2018 150 -19.6 -11.6% Dec 31, 2018
Q3 2018 175 +35.4 +25.4% Sep 30, 2018
Q2 2018 186 +57.8 +45.1% Jun 30, 2018
Q1 2018 191 +64.8 +51.2% Mar 31, 2018
Q4 2017 170 +44.9 +35.9% Dec 31, 2017
Q3 2017 139 +9.01 +6.91% Sep 30, 2017
Q2 2017 128 -9.07 -6.6% Jun 30, 2017
Q1 2017 127 -11.6 -8.37% Mar 31, 2017
Q4 2016 125 -10.6 -7.81% Dec 31, 2016
Q3 2016 130 -2.67 -2.01% Sep 30, 2016
Q2 2016 137 +10.8 +8.52% Jun 30, 2016
Q1 2016 138 +12.4 +9.83% Mar 31, 2016
Q4 2015 136 +9.04 +7.14% Dec 31, 2015
Q3 2015 133 +17.7 +15.4% Sep 30, 2015
Q2 2015 127 +9.72 +8.32% Jun 30, 2015
Q1 2015 126 +8.91 +7.63% Mar 31, 2015
Q4 2014 127 +11.3 +9.8% Dec 31, 2014
Q3 2014 115 -14.3 -11% Sep 30, 2014
Q2 2014 117 -9.76 -7.71% Jun 30, 2014
Q1 2014 117 -9.59 -7.59% Mar 31, 2014
Q4 2013 115 -11.3 -8.94% Dec 31, 2013
Q3 2013 130 +1.07 +0.83% Sep 30, 2013
Q2 2013 127 -4.2 -3.21% Jun 30, 2013
Q1 2013 126 -2.7 -2.09% Mar 31, 2013
Q4 2012 127 +7.12 +5.96% Dec 31, 2012
Q3 2012 128 +15.9 +14.1% Sep 30, 2012
Q2 2012 131 +25.6 +24.3% Jun 30, 2012
Q1 2012 129 +28.6 +28.5% Mar 31, 2012
Q4 2011 120 Dec 31, 2011
Q3 2011 113 Sep 30, 2011
Q2 2011 105 Jun 30, 2011
Q1 2011 101 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.